Dawn Giangiulio

Dawn Giangiulio has over 20 years of experience in accounting and finance. Dawn began their career in 1999 as a Senior Audit Associate at PricewaterhouseCoopers. In 2001, they became the Controller at Emerald Connect, Inc. In 2013, they worked as a Consultant at Resources Global Professionals. From 2014 to 2015, they were the Senior Accounting Manager at Auspex Pharmaceuticals, Inc., which was acquired by Teva Pharmaceuticals in 2015. At Teva Pharmaceuticals, they were a Senior Manager R&D Finance from 2015 to 2020. In 2020, they became the Controller at ARS Pharmaceuticals, Inc. and the Senior Director, Accounting at Design Therapeutics.

Dawn Giangiulio obtained their Bachelor's of Science in Commerce with a major in Accounting from Santa Clara University in 1999. Dawn attended Santa Clara University from 1995 to 1999.